Treatment of Insulin-Resistant Diabetic Ketoacidosis with Insulin-like Growth Factor I in an Adolescent with Insulin-Dependent Diabetes

New England Journal of Medicine

Volumn 327, Issue 12, 1992, Pages 853-857

  Usala, Anton Lewis ^a   Madigan, Timothy ^a   Burguera, Bartolome ^a   Sinha, Madhur K ^a   Caro, Jose F ^a   Cunningham, Paul ^b   Powell, John G ^a   Butler, Peter C ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN C;

ADIPOCYTE; ADOLESCENT; ARTICLE; CASE REPORT; DIABETIC KETOACIDOSIS; DRUG BINDING; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; HYPOPHOSPHATEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KETOGENESIS; LIPOLYSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADIPOSE TISSUE; ADOLESCENT; CASE REPORT; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETIC KETOACIDOSIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSE; HUMAN; IN VITRO; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; PHOSPHATES; POTASSIUM; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026758821     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199209173271205     Document Type: Article

References (20)

1. Berson SA, Yalow RS. Insulin “antagonists” and insulin resistance. In: Ellenberg M, Rifkin H, eds. Diabetes mellitus: theory and practice. New York: McGraw-Hill, 1970:388–423.
2. Flier JS, Kahn CR, Roth J. Receptors, antireceptor antibodies and mechanisms of insulin resistance. N Engl J Med 1979; 300: 413–9.
3. Kadowaki T, Bevins CL, Cama A, et al. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 1988; 240: 787–90.
4. Williams G, Pickup JC, Keen H. Massive insulin resistance apparently due to rapid clearance of circulating insulin. Am J Med 1987; 82: 1247–52.
5. Czech MP. Structural and functional homologies in the receptors for insulin and insulin-like growth factors. Cell 1982; 31: 8–10.
6. Schoenle EJ, Zenobi PD, Torresani T, Werder EA, Zachmann M, Froesch ER. Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia 1991; 34: 675–9.
7. Garvey WT, Olefsky JM, Matthaei S, Marshall S. Glucose and insulin coregulate the glucose transport system in primary cultured adipocytes: a new mechanism of insulin resistance. J Biol Chem 1987; 262: 189–97.
8. Sinha MK, Taylor LG, Pories WJ, et al. Long-term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with and without non—insulin-dependent diabetes. J Clin Invest 1987; 80: 1073–81.
9. Sinha MK, Buchanan C, Leggett N, et al. Mechanism of IGF-I-stimulated glucose transport in human adipocytes: demonstration of specific IGF-I receptors not involved in stimulation of glucose transport. Diabetes 1989; 38: 1217–25.
10. Sinha MK, Raineri-Maldonado C, Buchanan C, et al. Adipose tissue glucose transporters in NIDDM: decreased levels of muscle/fat isoform. Diabetes 1991; 40: 472–7.
11. Kashiwagi MA, Verso A, Andrews J, Vasquez B, Reaven G, Foley JE. In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus. J Clin Invest 1983; 72: 1246–54.
12. Kitabchi AE. Low-dose insulin therapy in diabetic ketoacidosis: fact or fiction? Diabetes Metab Rev 1989; 5: 337–63.
13. Zapf J, Hauri C, Waldvogel M, Froesch ER. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J Clin Invest 1986; 77: 1768–75.
14. Guler H-P, Zapf J, Froesch ER. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 1987; 317: 137–40.
15. Jacob RJ, Sherwin RS, Bowen L, et al. Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats. Am J Physiol 1991; 260: E262–E268.
16. Rossetti L, Frontoni S, Dimarchi R, DeFronzo RA, Giaccari A. Metabolic effects of IGF-I in diabetic rats. Diabetes 1991; 40: 444–8.
17. Bhaumick B, Bala RM. Parallel effects of insulin-like growth factor-II and insulin on glucose metabolism of developing mouse embryonic limb buds in culture. Biochem Biophys Res Commun 1988; 152: 359–67.
18. Bhaumick. Differential effects of insulin-like growth factors I and II on growth, differentiation and glucoregulation in differentiating chondrocyte cells in culture. Acta Endocrinol (Copenh) 1991; 125: 201–11.
19. Verspohl EJ, Roth RA, Vigneri R, Goldfine ID. Dual regulation of glycogen metabolism by insulin and insulin-like growth factors in human hepatoma cells (HEP-G2): analysis with an antireceptor monoclonal antibody. J Clin Invest 1984; 74: 1436–43.
20. Kahn CR. The molecular mechanism of insulin action. Annu Rev Med 1985; 36: 429–51.